Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes? - PubMed (original) (raw)

Review

Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes?

S E Bulun. J Clin Endocrinol Metab. 1996 Mar.

No abstract available

PubMed Disclaimer

Similar articles

• Bone has a sexually dimorphic response to aromatase deficiency.
  Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R, Simpson ER. Oz OK, et al. J Bone Miner Res. 2000 Mar;15(3):507-14. doi: 10.1359/jbmr.2000.15.3.507. J Bone Miner Res. 2000. PMID: 10750565
• Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence.
  Belgorosky A, Guercio G, Pepe C, Saraco N, Rivarola MA. Belgorosky A, et al. Horm Res. 2009;72(6):321-30. doi: 10.1159/000249159. Epub 2009 Oct 21. Horm Res. 2009. PMID: 19844120 Review.
• Aromatase activity and bone homeostasis in men.
  Gennari L, Nuti R, Bilezikian JP. Gennari L, et al. J Clin Endocrinol Metab. 2004 Dec;89(12):5898-907. doi: 10.1210/jc.2004-1717. J Clin Endocrinol Metab. 2004. PMID: 15579733 Review.
• Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene.
  Hauri-Hohl A, Meyer-Böni M, Lang-Muritano M, Hauri-Hohl M, Schoenle EJ, Biason-Lauber A. Hauri-Hohl A, et al. Clin Endocrinol (Oxf). 2011 Jul;75(1):39-43. doi: 10.1111/j.1365-2265.2011.04012.x. Clin Endocrinol (Oxf). 2011. PMID: 21521281
• Of mice and men: the evolving phenotype of aromatase deficiency.
  Jones ME, Boon WC, Proietto J, Simpson ER. Jones ME, et al. Trends Endocrinol Metab. 2006 Mar;17(2):55-64. doi: 10.1016/j.tem.2006.01.004. Epub 2006 Feb 9. Trends Endocrinol Metab. 2006. PMID: 16480891 Review.

Cited by

• Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls.
  Sopher AB, Thornton JC, Silfen ME, Manibo A, Oberfield SE, Wang J, Pierson RN Jr, Levine LS, Horlick M. Sopher AB, et al. J Clin Endocrinol Metab. 2001 Nov;86(11):5269-72. doi: 10.1210/jcem.86.11.8045. J Clin Endocrinol Metab. 2001. PMID: 11701690 Free PMC article. Clinical Trial.
• The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.
  Mitwally MF, Casper RF, Diamond MP. Mitwally MF, et al. Reprod Biol Endocrinol. 2005 Oct 4;3:54. doi: 10.1186/1477-7827-3-54. Reprod Biol Endocrinol. 2005. PMID: 16202169 Free PMC article. Review.
• Defects of steroidogenesis.
  Biason-Lauber A, Boscaro M, Mantero F, Balercia G. Biason-Lauber A, et al. J Endocrinol Invest. 2010 Nov;33(10):756-66. doi: 10.1007/BF03346683. Epub 2010 Feb 24. J Endocrinol Invest. 2010. PMID: 20190554 Review.
• Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.
  Lee Y, Choi JH, Oh A, Kim GH, Park SH, Moon JE, Ko CW, Cheon CK, Yoo HW. Lee Y, et al. Ann Pediatr Endocrinol Metab. 2020 Jun;25(2):97-103. doi: 10.6065/apem.1938152.076. Epub 2020 Jun 30. Ann Pediatr Endocrinol Metab. 2020. PMID: 32615689 Free PMC article.
• GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.
  Ford J, Hajibeigi A, Long M, Hahner L, Gore C, Hsieh JT, Clegg D, Zerwekh J, Oz OK. Ford J, et al. J Bone Miner Res. 2011 Feb;26(2):298-307. doi: 10.1002/jbmr.209. J Bone Miner Res. 2011. PMID: 20734455 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems